Salvage therapy of reactive capillary hemangiomas: Apatinib alleviates the unique adverse events induced by camrelizumab in non-small cell lung cancer
J Cancer Res Ther
; 2020 Jan; 15(6): 1624-1628
Article
| IMSEAR
| ID: sea-213581
Full text:
1
Index:
IMSEAR
Type of study:
Observational_studies
Journal:
J Cancer Res Ther
Journal subject:
Neoplasms
/
Therapeutics
Year:
2020
Type:
Article